TTD | Drug: D03GPH

Drug General Information
Drug ID	D03GPH
Former ID	DNC014622
Drug Name	1-(4-Chloro-phenyl)-3-(3-pentyl-oct-2-enyl)-urea
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[527275]
Structure		Download 2D MOL 3D MOL
Formula	C20H31ClN2O
Canonical SMILES	CCCCCC(=CCNC(=O)NC1=CC=C(C=C1)Cl)CCCCC
InChI	1S/C20H31ClN2O/c1-3-5-7-9-17(10-8-6-4-2)15-16-22-20(24)23-19-13-11-18(21)12-14-19/h11-15H,3-10,16H2,1-2H3,(H2,22,23,24)
InChIKey	CIWRUSYLNXXOOQ-UHFFFAOYSA-N
PubChem Compound ID	44265967
Target and Pathway
Target(s)	Cholecystokinin receptor type A	Target Info	Inhibitor	[527275]
KEGG Pathway	Calcium signaling pathway
	Neuroactive ligand-receptor interaction
	Insulin secretion
	Pancreatic secretion
Reactome	Peptide ligand-binding receptors
Reactome	G alpha (q) signalling events
WikiPathways	GPCRs, Class A Rhodopsin-like
	Gastrin-CREB signalling pathway via PKC and MAPK
	Peptide GPCRs
	GPCR ligand binding
	GPCR downstream signaling
References
Ref 527275	J Med Chem. 1992 Mar 20;35(6):1042-9.Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.
Ref 527275	J Med Chem. 1992 Mar 20;35(6):1042-9.Hybrid cholecystokinin-A antagonists based on molecular modeling of lorglumide and L-364,718.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information